Text and Data Mining valid from 2019-09-18
Received: 16 February 2019
Accepted: 2 September 2019
First Online: 18 September 2019
Ethics approval and consent to participate
: This study was approved by the Institutional Review Board of Hospital Clínic de Barcelona. Reg. HCB/2015/1096. All patients provided written informed consent.
: Not applicable
: Advisory role of A.P. for Nanostring Technologies, Pierre Fabre, Roche, Pfizer, Novartis, BMS, and Roche. The other authors declare that they have no competing interests.